New nanosensor detects cancer biomarkers in drop of blood

New nanosensor detects cancer biomarkers in drop of blood
Credit: University of Twente

Looking for cancer biomarkers in blood is a promising method for detecting metastatic cancer. It is less demanding than imaging techniques like MRI (magnetic resonance imaging). The main challenge to overcome is the extremely low concentrations of these markers, which makes it difficult to detect them. Researchers of the University of Twente and Wageningen University developed a nanosensor that accurately detects biomarkers for cancer in an extremely broad range of concentrations, from 10 particles per microliter to 1 million particles per microliter. Their development was featured on the cover of Nano Letters, a journal of the American Chemical Society.

Tumor-derived extracellular vesicles (tdEVs) are attracting much attention due to their potential as . Although tdEVs are significantly more abundant in than other biomarkers, their concentration compared to other blood components remains relatively low. The presence of particles in blood with a similar size as that of tdEVs asks not only for a sensitive but also a selective sensor.

Two nanoscale combs

On the nanoscale, the sensor looks like two combs woven into each other, that leaves gaps between the teeth'—the electrodes—of around 120 nanometers. This small gap size provides amplification of the signal. The sensor has two levels of selection and two levels of amplification. This gives it the selectivity and sensitivity to accurately detect particles at low concentration. "The most unique feature of this sensor is that its sensitivity spans over six orders of magnitude. In contrast to other , it covers most of the clinically relevant range for tdEV detection in blood," says Dilu Mathew, one of the researchers at NanoElectronics group at University of Twente.

Mathew, winner of the Metrohm Young Chemist Award 2018, is currently working on a new sensor. He says: "The goal is to make a sensor that is able to detect a single tdEV in small amount of blood." His colleague Pepijn Beekman adds: "In the lab we've already shown that we can detect individual nanoparticles."

Credit: University of Twente

Explore further

Multi-modal analysis platform for capturing tumor-derived extracellular vesicles

More information: Dilu G. Mathew et al. Electrochemical Detection of Tumor-Derived Extracellular Vesicles on Nanointerdigitated Electrodes, Nano Letters (2019). DOI: 10.1021/acs.nanolett.9b02741
Journal information: Nano Letters

Citation: New nanosensor detects cancer biomarkers in drop of blood (2020, February 13) retrieved 29 November 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments